Hypocalcemia medical therapy

Jump to navigation Jump to search

Hypocalcemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypocalcemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypocalcemia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypocalcemia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypocalcemia medical therapy

CDC on Hypocalcemia medical therapy

Hypocalcemia medical therapy in the news

Blogs on Hypocalcemia medical therapy

Directions to Hospitals Treating Hypocalcemia

Risk calculators and risk factors for Hypocalcemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Cause, severity and the presence of symptoms guide the treatment of hypocalcemia. Mild to moderate cases of hypocalcemia can be treated by giving oral calcium and vitamin D supplements but in severe cases intravenous (IV) calcium gluconate is preferred. Most of the hypocalcemic cases are mild and require only supportive treatment and laboratory evaluation.

Medical Therapy

Therapeutic approach

  • Patients who are presenting with milder symptoms of neuromuscular irritability like paresthesias and corrected calcium levels more than 7.5 mg/dL treating with oral calcium and vitamin D supplements is of first choice.
  • Patients with milder hypocalcemia who are on the oral supplements and shows no sign of improvement the next best best step in treating would be switching to IV calcium.
  • And patients who are requiring intravenous (IV) repletion should be admitted.
    • Preferred regimen (1): Elemental calcium 1-3 g/d.

Severe Hypocalcemia

  • IV calcium is recommended for patients who shows symptoms of severe hypocalcemia like the following[5][6]
    • Carpopedal spasm
    • Tetany
    • Seizures
    • QT interval prolongation
  • IV calcium is recommended for asymptomatic patients whose serum corrected calcium levels are ≤7.5 mg/dL.
  • If left untreated asymptomatic patients may end up with serious complications.
  • Following post-radical neck dissection patients may end up with acute hypoparathyroidism which leads to acute hypocalcemia due to rapid reduction in serum calcium[7][8]
    • Preferred regimen (1): IV calcium gluconate 1 or 2 g in 50 mL of 5 percent dextrose or normal saline given over 10 to 20 minutes.
    • Due to risk of serious cardiac dysfunction, calcium should be given slowly.
  • Following should be considered while preparing the IV calcium infusion
    • Calcium should be diluted in dextrose or water because concentrated calcium is an irritant to veins.
    • IV infusion should not contain bicarbonate or phosphate.
  • Until the patient receives oral calcium and vitamin D, IV calcium should be continued.

Mild or Chronic hypocalcemia

  • When serum corrected calcium levels are between 7.5 to 8.0 mg/dL are considered as mild hypocalcemia.[9]
  • Oral calcium supplementation is preferred for the patients who are presenting with mild or chronic hypokalemia.
    • Preferred regimen (1): Elemental calcium( calcium carbonate or calcium citrate) 500 to 2000 mg in divided doses.

Contraindicated medications

Hypocalcemia is considered an absolute contraindication to the use of the following medications:

References

  1. Cooper MS, Gittoes NJ (June 2008). "Diagnosis and management of hypocalcaemia". BMJ. 336 (7656): 1298–302. doi:10.1136/bmj.39582.589433.BE. PMC 2413335. PMID 18535072.
  2. Carroll R, Matfin G (February 2010). "Endocrine and metabolic emergencies: hypocalcaemia". Ther Adv Endocrinol Metab. 1 (1): 29–33. doi:10.1177/2042018810366494. PMC 3474611. PMID 23148147.
  3. Cooper MS, Gittoes NJ (June 2008). "Diagnosis and management of hypocalcaemia". BMJ. 336 (7656): 1298–302. doi:10.1136/bmj.39582.589433.BE. PMC 2413335. PMID 18535072.
  4. Carroll R, Matfin G (February 2010). "Endocrine and metabolic emergencies: hypocalcaemia". Ther Adv Endocrinol Metab. 1 (1): 29–33. doi:10.1177/2042018810366494. PMC 3474611. PMID 23148147.
  5. Dickerson, Roland N. (2007). "Treatment of hypocalcemia in critical illness—part 1". Nutrition. 23 (4): 358–361. doi:10.1016/j.nut.2007.01.011. ISSN 0899-9007.
  6. Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M (August 2006). "Hypoparathyroidism and pseudohypoparathyroidism". Arq Bras Endocrinol Metabol. 50 (4): 664–73. PMID 17117292.
  7. Cayo AK, Yen TW, Misustin SM, Wall K, Wilson SD, Evans DB, Wang TS (December 2012). "Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study". Surgery. 152 (6): 1059–67. doi:10.1016/j.surg.2012.08.030. PMC 4538326. PMID 23068088.
  8. Raffaelli M, De Crea C, D'Amato G, Moscato U, Bellantone C, Carrozza C, Lombardi CP (January 2016). "Post-thyroidectomy hypocalcemia is related to parathyroid dysfunction even in patients with normal parathyroid hormone concentrations early after surgery". Surgery. 159 (1): 78–84. doi:10.1016/j.surg.2015.07.038. PMID 26456131.
  9. Harvey JA, Zobitz MM, Pak CY (June 1988). "Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate". J. Bone Miner. Res. 3 (3): 253–8. doi:10.1002/jbmr.5650030303. PMID 3213620.

Template:WH Template:WS